EPISODE · Sep 25, 2026 · 13 MIN
SHTG Digest — Friday September 25, 2026
from SHTG Daily Digest — Weiss Lab
A thin cycle on both fronts — the lipid literature offered only next-tier work (an ANGPTL3 base-editing delivery study, an APOC3 variant association in Indian MASLD, and two clinical-care papers on hypertriglyceridemia), and the industry side produced no new SHTG news, with the only fresh item being Ionis's partnered antisense drug sefaxersen hitting its Phase 3 interim endpoint in IgA nephropathy with Roche.
Embed this episode
Ready to play
SHTG Digest — Friday September 25, 2026
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.